Redx Pharma appoints Iain Ross as chairman

Maryam Cockar Sharecast | 20 Apr, 2017 09:51 | | |

pills tablets medicine drugs pharmaceutical
  • 13,961.69
  • 0.33%45.56
  • Max: 13,996.90
  • Min: 13,916.13
  • Volume: 0
  • MM 200 : n/a
17:30 21/07/17
  • 969.70
  • 0.22%2.11
  • Max: 972.57
  • Min: 967.34
  • Volume: 0
  • MM 200 : n/a
17:18 21/07/17
  • 32.37
  • 0.00%0.00
  • Max: 33.00
  • Min: 31.80
  • Volume: 17,701
  • MM 200 : n/a
17:17 21/07/17

AIM-listed Redx Pharma has appointed Iain Ross as chairman of its board and as a non-executive director, effective from 1 May.

Ross has over 35 years' experience having held senior positions at multiple public and private life sciences companies and is vice chairman of Royal Holloway, University of London.

He is also currently non-executive chairman of AIM quoted e-Therapeutics and Biomer Technology alongside his non-executive directorships at Premier Veterinary Group, Australia-listed Anatara LifeSciences and Novogen as well as being a director of Aldershot Town Football Club.

Chief executive Dr Neil Murray said that under Ross’ “stewardship the company will deliver shareholder value as we transition into a clinical-stage research and development company with a focus on cancer, immunology and infection”.

Ross said: "Redx Pharma is a business of the highest quality that has discovered high value assets in cancer, immunology and infection and the opportunity to be part of progressing these promising assets through the clinic was instantly appealing.

Shares in Redx Pharma were down 2.44% to 35p at 0908 BST.

More news

21 Jul Commodities: Increasing supply of oil weighs heavy on the market

An over supply of crude from Nigeria and Libya of approximately 1m barrels per day weighed heavily on the oil market on Friday with September contracts for both WTI crude and Brent crude down 2.28% and 2.29% respectively.

21 Jul Magnolia Petroleum announces divestment of North Dakota and Oklahoma wells

Magnolia Petroleum, an Oklahoma based oil and gas investment company, has divested and agreed farmouts over several wells in North Dakota and Oklahoma for a total of $411,000.

21 Jul Europe close: DAX dives on euro peaks and colluding carmakers

European stocks ended the week firmly in the red as the euro continued to march higher, with the strength in the single currency weighing on exporters and car makers were hit by reports of collusion in the industry, combining to send the Dax to new three-month lows.

21 Jul FX round-up: Lack of data release makes way for indecisive Cable moves

On Friday sterling managed to recover most of its losses against the US dollar from prior session posting a morning high of 1.3020, only managing to touch psychological resistance of 1.3000 briefly.

21 Jul London close: FTSE profit taking kicks shares into red

UK stocks were lacklustre on Friday as oil and stocks plunged but investors mulled yet more waxing and waning of Brexit negotiations, proving that uncertainty is the only certainty surrounding the issue.

21 Jul FTSE 100 movers: Paddy Power leads Friday retreat

London's FTSE 100 was in the red on Friday, along with stock benchmarks in Europe and the US.

21 Jul General Electric tumbles further as profits slide

US industrial giant General Electric reported net profits of $1.34bn for the second quarter of 2017, 53% less than its earnings for the same quarter in 2016.

21 Jul US open: Wall Street slips amid weak tech earnings, downbeat GE

Wall Street was slightly lower in early trading following disappointing updates from Microsoft and Ebay, alongside weak guidance from industrial conglomerate GE.

21 Jul Catalyst Media softens blow from failed Greyhound track bids

Retail betting service supplier Sports Information Services (SIS), in which Catalyst Media Group holds a 20.5% stake, has secured rights and media agreements for its greyhound and horseracing content.

21 Jul Dalata buys Hotel La Tour for £31m

AIM-listed Dalata has acquired Hotel La Tour for £31m from Hotel La Tour Limited, which owns the long leasehold interest in the hotel situated on Park Street in the centre of Birmingham.